Lacosamide 10mg/mL, 20mL Injection

Lacosamide 10mg/mL is an intravenous antiseizure medicine used when an oral lacosamide regimen is temporarily unsuitable. It is used for selected seizure types within an appropriate epilepsy regimen.
It is administered intravenously using the specified infusion procedure. Conversion between oral and intravenous treatment generally maintains the established total daily lacosamide exposure.
Lacosamide enhances slow inactivation of voltage-gated sodium channels, stabilising overactive nerve-cell firing.
Dizziness, nausea, headache, double vision and unsteadiness can occur. PR-interval prolongation, fainting and conduction block are important potential effects.
Heart-conduction disease and other medicines affecting cardiac conduction are relevant. An ECG may be needed before treatment and after dose titration in at-risk patients.
Maintains antiseizure treatment when swallowing or oral administration is not possible.
No. Both contain lacosamide; the route is changed to maintain treatment when oral administration is unsuitable.
Lacosamide can slow atrioventricular conduction and lengthen the PR interval.
No. Total milligrams depend on how many millilitres are administered.
The route can be changed, but abrupt withdrawal of antiseizure treatment can provoke seizures.
Sodium channel: a nerve-cell protein controlling electrical signalling. PR interval: an ECG measure of conduction from atria to ventricles. Focal seizure: a seizure beginning in one brain region.; AR: Lacosamide 10mg/mL, 20mL حقن; FR: Lacosamide 10mg/mL, 20mL injection; PT: Lacosamide 10mg/mL, 20mL injeção; ES: Lacosamide 10mg/mL, 20mL inyección; RU: Lacosamide 10mg/mL, 20mL инъекция; ID: Lacosamide 10mg/mL, 20mL injeksi; VI: Lacosamide 10mg/mL, 20mL thuốc tiêm; MS: Lacosamide 10mg/mL, 20mL suntikan; TL: Lacosamide 10mg/mL, 20mL iniksyon; ZH-SG: Lacosamide 10mg/mL, 20mL 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Lacosamide 10mg/mL, 20mL Injection under Neuro Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Lacosamide 10mg/mL, 20mL Injection